Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cell-based Therapeutics
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +48,80% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +48,80% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 58 | 11/07/16 | |
James Parslow
DFI | Director of Finance/CFO | 59 | 03/04/17 |
Curtis Lockshin
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/03/14 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 58 | 11/07/16 | |
Moshe Mizrahy
BRD | Director/Board Member | 71 | - |
Adam Logal
CHM | Chairman | 46 | 14/08/17 |
Dmitriy Genkin
BRD | Director/Board Member | 56 | 01/01/04 |
Roger Kornberg
BRD | Director/Board Member | 77 | 29/02/16 |
Director/Board Member | 72 | 23/01/14 | |
Director/Board Member | 54 | 19/07/19 | |
James Callaway
BRD | Director/Board Member | 68 | 14/08/17 |
Director/Board Member | 55 | 25/09/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 1 804 394 | 0 | 0 | 80,81 % |
Azione B | 1 | 1 543 385 | 1 247 242 ( 80,81 %) | 2 701 ( 0,1750 %) | |
Azione C | 0 | 970 000 | 0 | 0 |
Coordinate società
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+9,58% | 115 Mrd | |
+12,41% | 106 Mrd | |
-2,59% | 21,96 Mrd | |
-12,38% | 21,87 Mrd | |
-5,29% | 19,21 Mrd | |
-3,35% | 18,08 Mrd | |
-38,57% | 17,71 Mrd | |
+7,51% | 14,32 Mrd | |
+35,67% | 12,42 Mrd |